Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Evaluate Carotid Artery Plaque Composition by Magnetic Resonance Imaging in People Receiving Cholesterol Medication (CPC)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
National Heart, Lung, and Blood Institute (NHLBI)
Pfizer
Abbott
Daiichi Sankyo Inc.
Upsher-Smith Laboratories
Information provided by (Responsible Party):
Xue-Qiao Zhao, University of Washington
ClinicalTrials.gov Identifier:
NCT00715273
First received: July 11, 2008
Last updated: December 1, 2015
Last verified: December 2015